Cargando…

Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck

This phase II study determined response rate of patients with locally advanced or metastatic head and neck cancer treated with pemetrexed disodium, a new multitargeted antifolate that inhibits thymidylate synthase, dihydrofolate reductase and glycinamide ribonucleotide formyl transferase. 35 patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivot, X, Raymond, E, Laguerre, B, Degardin, M, Cals, L, Armand, J P, Lefebvre, J L, Gedouin, D, Ripoche, V, Kayitalire, L, Niyikiza, C, Johnson, R, Latz, J, Schneider, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364119/ https://www.ncbi.nlm.nih.gov/pubmed/11531245 http://dx.doi.org/10.1054/bjoc.2001.2010

Ejemplares similares

Synthesis and Physicochemical Characterization of the Impurities of Pemetrexed Disodium, an Anticancer Drug
por: Michalak, Olga, et al.
Publicado: (2015)

New Polymorphic Forms of Pemetrexed Diacid and Their Use for the Preparation of Pharmaceutically Pure Amorphous and Hemipentahydrate Forms of Pemetrexed Disodium
por: Michalak, Olga, et al.
Publicado: (2015)

A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
por: Couteau, C, et al.
Publicado: (1999)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
por: Etienne, M C, et al.
Publicado: (1999)

Vascular architecture and hypoxic profiles in human head and neck squamous cell carcinomas
por: Wijffels, K I E M, et al.
Publicado: (2000)

The role of genetic factors in predisposition to squamous cell cancer of the head and neck
por: Jefferies, S, et al.
Publicado: (1999)

Metabolism and growth inhibition of four retinoids in head and neck squamous normal and malignant cells
por: Klaassen, I, et al.
Publicado: (2001)

Evaluation of the Effects of Astragalus membranaceus on the Pharmacokinetics of Pemetrexed Disodium and Gemcitabine in Rats by a Simple High-Performance Liquid Chromatography/UV Method
por: Chu, Zixuan, et al.
Publicado: (2019)

Differential expression of a novel serine protease homologue in squamous cell carcinoma of the head and neck
por: Lang, J C, et al.
Publicado: (2001)

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer
por: Kaira, Kyoichi, et al.
Publicado: (2019)

Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas
por: Mineta, H, et al.
Publicado: (2000)

Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck
por: Posner, M R, et al.
Publicado: (2003)

PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma
por: Simon, C, et al.
Publicado: (1999)

p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy
por: Ganly, I, et al.
Publicado: (2000)

Proton therapy for non-squamous cell carcinoma of the head and neck: planning comparison and toxicity
por: Iwata, Hiromitsu, et al.
Publicado: (2019)

Telomerase activation cooperates with inactivation of p16 in early head and neck tumorigenesis
por: Soria, J C, et al.
Publicado: (2001)

Disodium 4,4′-oxydibenzoate
por: Yang, Yuan, et al.
Publicado: (2008)

Metabolomic analysis identifies differentially produced oral metabolites, including the oncometabolite 2-hydroxyglutarate, in patients with head and neck squamous cell carcinoma
por: Mukherjee, Pranab K., et al.
Publicado: (2016)

Effect of photodynamic therapy in combination with ionizing radiation on human squamous cell carcinoma cell lines of the head and neck
por: Allman, R, et al.
Publicado: (2000)

Prognostic value of the expression of epithelial cell adhesion molecules in head and neck squamous cell carcinoma treated by definitive radiotherapy
por: Murakami, Naoya, et al.
Publicado: (2019)

Long-term stability of gentamicin sulfate-ethylenediaminetetraacetic acid disodium salt (EDTA-Na(2)) solution for catheter locks
por: Fiolet, Anne-Sophie, et al.
Publicado: (2018)

A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck(†)
por: Seiwert, T. Y., et al.
Publicado: (2014)

Docetaxel in the treatment of squamous cell carcinoma of the head and neck
por: Rapidis, Alexander, et al.
Publicado: (2008)

No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours
por: Jefferies, S, et al.
Publicado: (2001)

Disodium tris(dioxidomolybdenum) bis(diarsenate)
por: Jouini, Raja, et al.
Publicado: (2012)

Fospropofol disodium injection for the sedation of patients undergoing colonoscopy
por: Levitzky, Benjamin E, et al.
Publicado: (2008)

High prevalence of p16 genetic alterations in head and neck tumours
por: Miracca, E C, et al.
Publicado: (1999)

Carboplatin-Pemetrexed in Treatment of Patients with Recurrent/Metastatic Cancers of the Head and Neck; Superior Outcomes in Oropharyngeal Primaries
por: Malhotra, Binu, et al.
Publicado: (2015)

A unified definition of clinical anthracycline resistance breast cancer
por: Pivot, X, et al.
Publicado: (2000)

Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden
por: Boffetta, P, et al.
Publicado: (2001)

Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03
por: Fayette, Jerome, et al.
Publicado: (2017)

A phase I study of pemetrexed (LY231514) supplemented with folate and vitamin B(12) in Japanese patients with solid tumours
por: Nakagawa, K, et al.
Publicado: (2006)

Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
por: Haddad, R I, et al.
Publicado: (2018)

Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules
por: Li, K M, et al.
Publicado: (2007)

The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma
por: Ishinaga, Hajime, et al.
Publicado: (2023)

Disodium (2RS,3SR)-tartrate
por: Arbuckle, William, et al.
Publicado: (2009)

Microvessel density in head and neck squamous cell carcinoma
por: Szafarowski, Tomasz, et al.
Publicado: (2018)

Lymph node or perineural invasion is associated with low miR-15a, miR-34c and miR-199b levels in head and neck squamous cell carcinoma
por: Sousa, Lucas O., et al.
Publicado: (2016)

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup
por: Garrido, Pilar, et al.
Publicado: (2017)

Hyperhydration with cisplatin does not influence pemetrexed exposure
por: de Rouw, Nikki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6t0q4bvle4hjnu3aefiofts7md